Medicines Authority Logo
  • SiteMap
  • Careers
Decrease Font Size Reset Font Size Increase Font Size

  • Home

  • Organisation

    • About Us
      • Mission and Objectives
      • Directorates and Units
      • Committees and Working Groups
      • Annual Reports
      • Heads of Medicines Agencies
      • Working at the Medicines Authority
      • Career Opportunities
      • Bank and Payment Details
    • Data and Information
      • Freedom of Information
      • Data Protection
      • Presentations and Publications
    • Links
      • Pharmacy Roster
      • eHealth
      • Government of Malta
      • Heads of Medicines Agency
      • Innovative Medicines Initiative
      • European Medicines Agency
    • Home

  • Legislation

    • Introduction
      • Better Regulation
    • Legislation Documentation
      • Medicines Act
      • EU Legislation
    • Home

  • Consultation

    • EU & Medicines Authority Consultations
      • EU & Medicines Authority Consultations
    • Home

  • News & Events

    • News
      • Press Releases
      • Circulars
      • Other News
      • Past News
    • Events
      • Latest Events
      • Past Events
    • Home

  • Online Services

    • Online Services
      • Eudrapharm
      • EU Common Submission Portal
      • Medicines Authority Notifications
      • Servizz.gov.mt
      • Online Applications (E-Forms)
    • Home

  • Contact and Connect

    • On Line Forms
      • Enquiries and Feedback
      • Complaints
      • Complaints related to Advertising of Medicinal Products
      • Report Product Defect
      • Report a Side Effect - Adverse Drug Reaction (ADR)
    • Connect and Share
      • Engage with us on Facebook
      • Follow us on LinkedIn
      • Follow us on Twitter
      • Connect with us on Google
      • Watch our videos on YouTube
    • Find Us
      • Contact Details
    • Home
  • Search for Malta Medicine
    Search »
    Search »
    Advanced Search »
  • Patient/Consumer
  • Industry
  • Healthcare Professional
  • News
  • Events

Activities

  • Registration of Medicinal Products
  • Pharmaceutical Activities and Inspections
  • Scientific Advice
  • Recalls and Rapid Alerts
  • Changes to prescription status
  • Safety Recalls
  • BREXIT - Regulatory considerations
  • Advanced Scientific Initiatives
  • Advertising
  • Borderline Products
  • Linguistic Checks
  • Safety
  • Clinical Trials
  • Enforcement and Market Surveillance

Testing Page

  • Home
  • >
  • Organisation
  • >
  • Links
  • >
    • Testing Page

Section 1 | Section 2 | Section 3

Section 1

Contact William

Document 1 - 03/15/2012 - MT4554A

  Medicines Authority Circular No P06/2012 Re: European Medicines Agency confirms positive benefit-risk balance of orlistat-containing medicines- 20.02.2012

Medicines Authority Circular No P05/2012 Re: European Medicines Agency recommends lifting of the suspension of aprotinin- 20.02.Ô

 

Photo taken place at Conference

Medicines Authority Circular No P04/2012 Re: European Medicines Agency reviews dose recommendations for anti-tuberculosis medicines used in children- 20.02.2012

 

Medicines Authority Circular No P03/2012 Re: European Medicines Agency recommends new contraindications and warnings for aliskiren-containing medicines - 20.02.2012

 

     
       
       
       
       
       
       
   

 

 

 

 

 

 

 

 

 

 

 

 

 

Back to Top
  • Facebook
  • You Tube
  • Twitter
  • LinkedIn
  • Google Plus
  • Marker

Medicines Authority
Sir Temi Żammit Buildings,
Malta Life Sciences Park,
San Ġwann SĠN 3000
Malta

E-mail: info.medicinesauthority@gov.mt

Telephone: 356 2343 9000 (from 7:30 to 15:45)

Helpline: 356 2343 9111 (from 9:00 to 12:00)

Fax: 356 2343 9161

  • gov mt logo
  • hma logo
  • picis logo
  • MCCAA Logo
  • NCPE Logo
Malta Medicine Authority © Copyright 2020
  • Accessability
  • Disclaimer
  • Privacy Policy
  • Freedom of Information
  • Copyright
  • Contact and Connect